-
Clinical trial tests combinations of immunotherapy drugs for prostate cancer
-
Committing to cell division may be clue to cancer cell growth
-
Fighting a rare central nervous system tumor with research and optimism
-
Antibody-linked drug shrinks various types of tumors in preclinical study
-
Clinical trial tests combination therapy for prostate cancer
-
RT @NCIBillDahut: One should never be surprised by the innovative approaches taken by @gulleyj1 and @Dr_RaviMadan! https://t.co/USCi4iRuSw
-
Registration is open for the September 27-28, 2018 Frontiers in Basic Immunology symposium #ImmunologyNCI2018. Regi… https://t.co/6XP65aoNJl
-
RT @gulleyj1: Enrolling now. Call 240-858-3148 to refer a patient. @Dr_RaviMadan @BernardAFox @ChrisHeery @HSaterMD https://t.co/vsd4kospUd
-
RT @NCICCR_VB: #Cancer #Immunotherapy saves lives. https://t.co/cixcwlS2N8 Here is the story of a brave woman with… https://t.co/klUuawoI94
-
#CIM18 Interested in the latest #clinicaltrials taking place @NIHClinicalCntr and @NCIResearchCtr? This video from… https://t.co/yoasAjB2xA
-
RT @historyatnih: DYK the first patient to be admitted to the NIH @NIHClinicalCntr was in 1953? The opening day of America's researc… https://t.co/HCbsuhuyZ2
-
RT @rosiekaplanmd: #AACRDRD thrilled with the excellent dialogue in metastatic niches session I was honored to cochair with Dahlit Bar… https://t.co/lUBoc3iciC
